Advertisement
Review Article| Volume 30, ISSUE 3, P677-692, September 2010

Modifying Risk for Aneuploidy with Second-Trimester Ultrasound After a Positive Serum Screen

  • Diane Timms
    Correspondence
    Corresponding author.
    Affiliations
    Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Connecticut Health Center-School of Medicine-John Dempsey Hospital, 263 Farmington Avenue, Room CG 214, Farmington, CT 06030-2946, USA
    Search for articles by this author
  • Winston A. Campbell
    Affiliations
    Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Connecticut Health Center-School of Medicine-John Dempsey Hospital, 263 Farmington Avenue, Room CG 214, Farmington, CT 06030-2946, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy.
        JAMA. 1976; 236 (NICHD National Registry for Amniocentesis Study Group): 1471-1476
        • Tabor A.
        • Madsen M.
        • Obel E.B.
        • et al.
        Randomized controlled trial of genetic amniocentesis in 4606 low-risk women.
        Lancet. 1986; 1: 1287-1293
        • Egan J.F.X.
        • Benn P.
        • Borgida A.F.
        • et al.
        Efficacy of screening for fetal Down syndrome in the United States from 1974–1997.
        Obstet Gynecol. 2000; 96: 979-985
        • Merkatz I.R.
        • Nitowsky H.M.
        • Macri J.N.
        • et al.
        An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.
        Am J Obstet Gynecol. 1984; 148: 886-894
        • Cuckle H.S.
        • Wald N.J.
        • Lindenbaum R.H.
        Maternal serum alpha-fetoprotein measurement: a screening test for Down's syndrome.
        Lancet. 1984; 323: 926-929
        • Bogart M.H.
        • Pandian M.R.
        • Jones O.W.
        Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities.
        Prenat Diagn. 1987; 7: 623-630
        • Canick J.A.
        • Knight G.J.
        • Palomaki G.E.
        • et al.
        Low second-trimester serum unconjugated oestriol in pregnancies with Down's syndrome.
        Br J Obstet Gynaecol. 1988; 95: 330-333
        • Cuckle H.
        Established markers in second-trimester serum.
        Early Hum Dev. 1996; 47: S27-S29
        • Wald N.J.
        • Densem J.
        • George L.
        • et al.
        Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
        Prenat Diagn. 1996; 16: 143-153
        • Benacerraf B.R.
        • Neuberg B.
        • Bromley B.
        • et al.
        Sonographic scoring index for prenatal detection of chromosomal abnormalities.
        J Ultrasound Med. 1992; 9: 449-458
        • Vintzileos A.M.
        • Campbell W.A.
        • Rodis J.F.
        • et al.
        The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21.
        Obstet Gynecol. 1996; 87: 948-952
        • Hobbins J.C.
        • Lezotte D.C.
        • Persutte W.H.
        • et al.
        An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies.
        J Ultrasound Med. 2003; 22: 33-38
        • Spencer K.
        • Souter V.
        • Tul N.
        • et al.
        A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free ß-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
        Ultrasound Obstet Gynecol. 1999; 13: 231-237
        • Wapner R.
        • Thom E.
        • Simpson J.L.
        • et al.
        First-trimester screening for trisomies 21 and 18. First-trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group.
        N Engl J Med. 2003; 349: 1405-1413
        • ACOG Practice Bulletin No. 77
        Screening for fetal chromosomal abnormalities.
        Obstet Gynecol. 2007; 109: 217-227
        • Benacerraf B.R.
        • Barss V.A.
        • Laboda L.A.
        A sonographic sign for the detection in the second-trimester of the fetus with Down's syndrome.
        Am J Obstet Gynecol. 1985; 151: 1078-1079
        • Benacerraf B.R.
        • Frigoletto F.D.
        • Laboda L.A.
        Sonographic diagnosis of Down syndrome in the second-trimester.
        Am J Obstet Gynecol. 1985; 153: 49-52
        • Nyberg D.A.
        • Souter V.L.
        Sonographic markers for fetal trisomies: second trimester.
        J Ultrasound Med. 2001; 20: 655-674
        • Benacerraf B.R.
        The role of the second-trimester genetic sonogram in screening for fetal Down syndrome.
        Semin Perinatol. 2005; 29: 386-394
        • Paladini D.
        • Tartaglione A.
        • Agangia A.
        • et al.
        The association between congenital heart disease and Down syndrome in prenatal life.
        Ultrasound Obstet Gynecol. 2000; 15: 104-108
        • Respondek-Liberska M.
        • Nowicki G.
        • Krason A.
        • et al.
        Can we suspect fetal down syndrome by heart evaluation during the second half of pregnancy?.
        Fetal Diagn Ther. 1999; 14: 143-148
        • Driscoll D.A.
        • Gross S.
        Prenatal screening for aneuploidy.
        N Engl J Med. 2009; 360: 2556-2562
        • McGee S.
        Simplifying likelihood ratios.
        J Gen Intern Med. 2002; 17: 646-649
        • Jaeschke R.
        • Guyatt G.H.
        • Sackett D.L.
        Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.
        JAMA. 1994; 271: 703-707
        • Smith-Bindman R.
        • Chu P.
        • Goldberg J.D.
        Second-trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down' syndrome.
        Prenat Diagn. 2007; 27: 535-544
        • Benacerraf B.R.
        • Gelman R.
        • Frigoletto F.
        Sonographic identification of second-trimester fetuses with Down's syndrome.
        N Engl J Med. 1987; 317: 1371-1376
        • Benacerraf B.R.
        • Neuberg D.
        • Frigoletto F.
        Humeral shortening in second-trimester fetuses with Down syndrome.
        Obstet Gynecol. 1991; 77: 223-227
        • Johnson M.P.
        • Michaelson J.E.
        • Barr M.
        • et al.
        Combining humerus and femur length for improved ultrasonographic identification of pregnancies at increased risk for trisomy 21.
        Am J Obstet Gynecol. 1995; 172: 1229-1235
        • Smith-Bindman R.
        • Hosmer W.
        • Feldstein V.
        Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis.
        JAMA. 2001; 285: 1044-1055
        • Nyberg D.
        • Dubinsky T.
        • Resta R.
        • et al.
        Echogenic fetal bowel during the second-trimester: clinical importance.
        Radiology. 1993; 188: 527-531
        • Bromley B.
        • Lieberman E.
        • Laboda L.
        • et al.
        Echogenic intracardiac focus: a sonographic sign for fetal Down's syndrome.
        Obstet Gynecol. 1995; 86: 998-1001
        • Viora E.
        • Errante G.
        • Sciarrone A.
        • et al.
        Fetal nasal bone and trisomy 21 in the second-trimester.
        Prenat Diagn. 2005; 25: 511-515
        • Bromley B.
        • Lieberman E.
        • Shipp T.D.
        • et al.
        Fetal nasal bone length. A marker for Down syndrome in the second-trimester.
        J Ultrasound Med. 2002; 21: 1387-1394
        • Cicero S.
        • Sonek J.D.
        • Mckenna D.S.
        • et al.
        Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation.
        Ultrasound Obstet Gynecol. 2003; 21: 15-18
        • Letierri L.
        • Rodis J.F.
        • Vintzileos
        • et al.
        Ear length in second-trimester aneuploid fetuses.
        Obstet Gynecol. 1993; 81: 57-60
        • Chitkara U.
        • Lee L.
        • Oehlert J.L.
        • et al.
        Fetal ear length measurement: a useful predictor of aneuploidy?.
        Ultrasound Obstet Gynecol. 2002; 19: 131-135
        • Wilkins I.
        Separation of the great toe in fetuses with Down syndrome.
        J Ultrasound Med. 1994; 13: 229-231
        • Bottalico J.
        • Chen X.
        • Tartaglia M.
        • et al.
        Second-trimester genetic sonogram for detection of fetal chromosomal abnormalities in a community-based antenatal testing unit.
        Ultrasound Obstet Gynecol. 2009; 33: 161-168
        • Nyberg D.A.
        • Luthy D.A.
        • Resta B.C.
        • et al.
        Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second-trimester: description of the method and analysis of 142 cases.
        Ultrasound Obstet Gynecol. 1998; 12: 8-14
        • Aagaard-Tillery K.M.
        • Malone F.D.
        • Nyberg D.A.
        • et al.
        Role of second-trimester genetic sonography after Down's syndrome screening.
        Obstet Gynecol. 2009; 114: 1189-1196
        • Vintzileos A.
        • Egan J.
        Adjusting the risk of trisomy 21 on the basis of second-trimester ultrasonography.
        Am J Obstet Gynecol. 1995; 172: 837-844
        • Benn P.A.
        • Egan J.F.
        Expected performance of second-trimester maternal serum testing followed by a ‘genetic sonogram’ in screening of fetal Down syndrome.
        Prenat Diagn. 2008; 28: 230-235
        • Wald NJ
        • Watt HC
        • Hackshaw AK
        Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
        N Engl J Med. 1999; 341: 461-467
        • Malone F.D.
        • Canick J.A.
        • Ball R.H.
        • et al.
        First-trimester or second-trimester screening, or both for Down's syndrome.
        N Engl J Med. 2005; 353: 2001-2011
        • Krantz D.A.
        • Hallahan T.W.
        • Macro V.J.
        • et al.
        Genetic sonography after first-trimester Down syndrome screening.
        Ultrasound Obstet Gynecol. 1993; 168: 534-538
        • Wax J.R.
        • Pinnette M.G.
        • Cartin A.
        • et al.
        Second-trimester genetic sonography after first-trimester combined screening for trisomy 21.
        J Ultrasound Med. 2009; 28: 321-325
        • Weisz B.
        • Pandya P.P.
        • David A.L.
        • et al.
        Ultrasound findings after screening for Down's syndrome using the integrated test.
        Obstet Gynecol. 2007; 109: 1046-1052